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Introducción. Explorar el consumo de cánnabis sigue siendo complejo 
debido a la falta de sistemas de registro. Se evaluó la factibilidad 
de obtener una Unidad de Porro Estándar (UPE) que considere 
los principales cannabinoides con implicación clínica mediante un 
estudio naturalístico.
Metodología. Estudio piloto con consumidores actuales de cánnabis 
de cuatro áreas (universidades, ocio nocturno, servicio ambulatorio 
de salud mental y asociaciones cannábicas) en Barcelona. Se 
diseñó y administró un cuestionario sobre patrones de consumo 
y se determinó la predisposición a donar un porro para análisis. Se 
utilizaron estadísticos descriptivos para analizar los datos.
Resultados. Cuarenta consumidores de cannabis respondieron a 
la encuesta (tasa de respuesta 95%), siendo la mayoría hombres 
(72,5%) y jóvenes adultos (mediana de edad 24,5 años; RIQ 8,75 
años) que consumen a diario o casi diariamente (70%). La marihuana 
es el derivado más consumido (85%), habiendo de mediana 0,25 gr 
de marihuana por porro. Un 67,5% de los participantes se mostraron 
predispuestos a donar un porro para análisis. 
Conclusión. La obtención de la UPE con la metodología prevista 
es factible. Tras el piloto el cuestionario ha sido adaptado y se ha 
introducido un incentivo para estimular la donación de muestras. 
Establecer la UPE permitirá avanzar en el conocimiento de las 
consecuencias del consumo de cannabis.
Palabras clave: Cannabis; 9-Tetrahidrocannabinol; unidad estándar; 
estudio piloto.
Introduction. Assessing cannabis consumption remains complex 
due to no reliable registration systems. We tested the likelihood of 
establishing a Standard Joint Unit (SJU) which considers the main 
cannabinoids with implication on health through a naturalistic 
approach.  
Methodology. Pilot study with current cannabis users of four areas 
of Barcelona: universities, nightclubs, out-patient mental health 
service, and cannabis associations. We designed and administered 
a questionnaire on cannabis use-patterns and determined the 
willingness to donate a joint for analysis. Descriptive statistics were 
used to analyze the data. 
Results. Forty volunteers answered the questionnaire (response rate 
95%); most of them were men (72.5%) and young adults (median age 
24.5 years; IQR 8.75 years) who consume daily or nearly daily (70%). 
Most participants consume marihuana (85%) and roll their joints 
with a median of 0.25 gr of marihuana. Two out of three (67.5%) 
stated they were willing to donate a joint.
Conclusion. Obtaining an SJU with the planned methodology has 
proved to be feasible. Pre-testing resulted in an improvement of the 
questionnaire and retribution to incentivize donations. Establishing 
an SJU is essential to improve our knowledge on cannabis-related 
outcomes. 
Keywords: Cannabis; 9-Tetrahydrocannabinol; standard unit; pilot 
study.
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Cannabis is the most abused illicit drug worldwi-de (United Nations Office on Drugs and Crime, 2015). In 2013 , 30% of the Spanish population between 15-64 years declared to have consumed 
cannabis once in their lives (Delegación del Gobierno para 
Plan Nacional sobre Drogas, 2015). Little is known on which 
consumption patterns increase the possibility of suffering 
cannabis-related consequences. Evaluating cannabis health 
outcomes faces several difficulties, as for example dealing 
with its variable composition or different quantities consu-
med. As a result, although doses have shown to be essential 
to evaluate drug-related outcomes, cannabis use is often 
only described by the frequency of use (Mariani, Brooks, 
Haney, & Levin, 2011; Norberg, Mackenzie, & Copeland, 
2012; van der Pol et al., 2013; Walden & Earleywine, 2008). 
One example are characterizations of risky cannabis use, 
as for example daily use (Coffey, Lynskey, Wolfe, & Patton, 
2000). However, specific information on the type of canna-
bis and its potency (concentration of 9-Tetrahydrocannabi-
nol) is often missing, ignoring its importance when evalua-
ting related health outcomes (Di Forti et al., 2009).
With alcohol, which is also characterized by a huge va-
riability between types of beverages, similar difficulties were 
tackled establishing a standard unit (Miller, Heather, & Hall, 
1991; Rodríguez-Martos Dauer, Gual Solé, & Llopis Llácer, 
1999; Stockwell, Blaze-Temple, & Walker, 1991). Nowadays 
the “standard drink” is widely used in alcohol assessment 
and has contributed to the characterization of risky users, 
enabling public health recommendations. 
Working on a homogenization of cannabis assessment 
could lead to equivalent benefits. A standard unit for can-
nabis would allow describing cannabis use patterns not only 
using frequency but also quantity. Few attempts to develop 
cannabis units have been published (Norberg et al., 2012; 
Zeisser et al., 2012). However, they show several weaknes-
ses. For example, units base on grams of cannabis and do 
not consider that cannabis can have a high variability in its 
composition (EMCDDA, 2008). Meanwhile, quantity of can-
nabis’ main psychoactive cannabinoid - 9-Tetrahydrocanna-
binol (9-THC) (Mechoulam & Gaoni, 1964) - present in the 
proposed units remains unknown. As well as the “standard 
drink” accounts for grams of alcohol, a standardized unit 
for cannabis should consider the quantity of its main psy-
choactive constituent with implication on health (Hall & 
Degenhardt, 2009; Hall, 2015). In addition, standard units 
should be based on the most used administration form. For 
cannabis, smoking a rolled cigarette in form of a joint, is 
the most common administration form (U.S. Department 
of Health and Human Services, 2014).
The Spanish Ministry of Health, through its National 
Plan on Drugs, recently approved a project to establish a 
“Standard Joint Unit” (SJU). This unit will consider the 
quantity of 9-THC in donated joints. In order to check the 
likelihood of obtaining a SJU through a naturalistic study, a 
pilot test was conducted. The present paper reports its main 
results and analyzes preliminary data.
Material and methods
Sample 
During September to December 2014 forty cannabis users 
were recruited by convenience in four different settings of 
Barcelona (Spain): universities, cannabis associations, one 
out-patient mental health service and nightclubs (N=10 in 
every setting). For the pilot study, the sample size was adjus-
ted to 10% of the expected final study sample. Participant’s 
eligibility criteria were (1) having consumed cannabis at 
least once in the last 60 days, (2) being able to decide to 
participate and 3) being adult. 
Procedure
Participants were informed about the study objective, 
anonymity and confidentiality of their data. Once accepted, 
they were administered a questionnaire. For the out-patient 
mental health service recruitment proceeded indirectly via 
informed psychiatrist who invited their patients to participate. 
Instruments
Questionnaires previously used in similar contexts were 
reviewed for suitable questions (Ministerio de Sanidad, 
Servicios Sociales e Igualdad, 2015; Ministerio de Sanidad, 
Servicios Sociales e Igualdad, 2013; Villalbí, Suelves, Saltó, 
& Cabezas, 2011). Finally the pilot questionnaire included 
15 questions, which can be divided into four groups: 1) So-
cio-demographical variables (sex, age, marital status, highest 
educational level achieved and current employment status); 
2) Patterns of cannabis use (type of cannabis derivate used, 
tobacco proportion used in joints, preparation of joints, fre-
quency of cannabis consumption in the last 30 days, mean 
joints smoked on one typical occasion in the previous 30 
days, joint sharing); 3) Preliminary data on the SJU (speci-
fied below) and predisposition to donate a joint for analysis; 
4) Main reason for cannabis use and the Cannabis Abuse 
Screening Test (CAST) (Cuenca-Royo et al., 2012; Legleye, 
Karila, Beck, & Reynaud, 2007). 
CAST screens for risk of problematic cannabis use, and 
consists of six questions, which can be answered with the 
options “never”, “rarely”, “from time to time”, “fairly often” 
and “very often”. Using the binary CAST option, final scores 
can be matched to either non problematic use (0-1), low 
risk of having cannabis-related problems (2-3) or high risk 
of having cannabis related problems (4-6). (Delegación del 
Gobierno para el Plan Nacional sobre Drogas, 2009).
The construction of the SJU is based on the following 
data: type of derivate consumed, weekly expenditure on 
cannabis, weekly amount of grams consumed, weekly num-
ber of joints consumed and frequency of acquisition. Du-
ring the pilot-test, no joints were collected for analysis. 
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Table 1. Socio-demographical characteristics of the sample 
recruited for the pilot study (N=40).























Highest educational level achieved
Primary school (6 years of school completed) 1 (2,5)
4 years of secondary school completed 9 (22,5)
5 or more years of secondary school competed 14 (35,0)




Currently absent from work 5 (12,5)
Receiving a disability pension 3 (7,5%)
Other situations without earning money 2 (5.0%)
For the final study joints will be analyzed using HPLC-UV, 
according to the recommended methods for the identifica-
tion and analysis of cannabis and cannabis products by the 
United Nations Office on Drugs and Crime using HPLC-UV 
(United Nations Office on Drug and Crime, 2009). 
Data Analysis
Descriptive statistical analyses were made using SPSS 
version 19. Percentages were used for categorical data and 
median, range and interquartile range for quantitative data.
Ethics statement
The study protocol was approved by the Committee on 
Ethics of the Hospital Clínic (HCB/2014/0770). No infor-
med consent was necessary due to anonymous participation. 
Study procedures were planned according to the Declara-




Recruitment proceeded without incidents and with a res-
ponse rate of 95%. The designed questionnaire needed mini-
mal changes like some additional response options. Only the 
question on the frequency of cannabis consumption in the last 
12 months had to be reviewed due to incorrect formulation.
Sample description and preliminary data
a) Socio-demographical data
Participants (N=40) were mostly men (72.5%), young 
adults (median 24.5 years, range 18-47) and single (72.5%). 
At the moment of the survey, 40% had finished their secon-
dary studies and 42.5% were working (Table 1). 
b) Consumption patterns
Our sample consumed marihuana (85%), hashish (10%) 
and hashish oil (5%). Home-grown marihuana was the first 
supply in 34% of the marihuana users, who occasionally also 
acquired cannabis if their plants were not productive. The 
majority (70%) affirmed to smoke on more than 20 days in 
the last month, 55% declared to smoke 2 to 4 joints per smo-
king occasion and 68.5% usually do not share their joints. 
85% stated to roll their joints similarly every time and 90% 
smoked cannabis with tobacco (Table 2).
c) Preliminary data on SJU and predisposition to donate a joint
Participants declared to roll 4 joints (median value) 
with 1 gram of cannabis (0.25 gr of cannabis/ joint). This 
Table 2. Description of consumption patterns and CAST scores of 
the recruited sample (N=40).
Item asked N (%)
Type of derivate consumed
Marihuana obtained in a cannabis association 18 (45,0%)
Home-gown marihuana 12 (30,0%)
Marihuana obtained in the illicit market 2 (5,0%)
Hashish 4 (10,5%)
Hashish oil 2 (5,0%)
Missing (several types of cannabis) 2 (5.0%)
Tobacco use to roll the joint 36 (90.0%)
Prepares the joints similarly 34 (85.0%)
Frequency of consumption in the last 30 days
More than 20 days 28 (70,0%)
Between 10 and 19 days 4 (10,0%)
Up to 9 days 8 (20.0%)
Number of joints consumed in one typical occasion
1 joint 8 (20,0%)
2-4 joints 22 (55,0%)
6-8 joints 5 (12,5%)
More than 9 joints 2 (5,0%)
Missing (consumed less than one joint per occasion) 3 (7.5%)
Shares the joint in most of the cases 13 (32.5%)
a CAST scores
0-1 (non-problematic use) 2 (5,0%)
2-3 (low risk use) 15 (37,5%)
4 or more (high risk use) 23 (57.5%)
Note. a CAST: Cannabis Abuse Screening Test
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proportion was similar for marihuana and hashish (Mari-
huana IQR=1.92; Hashish IQR=2.25). Preliminary data su-
ggests that one joint costs on average less than 2 € (data not 
shown in tables). Two out of three participants stated that 
they would donate a joint without receiving any retribution 
(67.5%). Thirteen individuals denied (6 at nightclubs, 4 at 
universities, 2 in out-mental health service and 1 in the can-
nabis association). Main reasons were not receiving retribu-
tion and wanting to smoke their joints. 
d) Main reasons for consumption and CAST scores
Main reasons for cannabis consumption were seeking 
for positive feelings as for example pleasure (70%), avoid 
negative feelings as for example anxiety (20%) and neutral 
reasons as for example habit (10%). CAST scores were in 
57.5% higher than 4 points (high-risk use).
Discussion
Planned methodology to establish a SJU was tested. Par-
ticipant’s predisposition to donate a joint indicates that 
working on a SJU obtained through a naturalistic study 
approach is feasible. Additional data related to cannabis use 
could be retrieved with a questionnaire which needed mini-
mal changes. 
Study procedure and questionnaire
One out of three participants affirmed not to be pre-
disposed to donate a joint, often due to no retribution. In 
order to incentivize joints donations, non-economical retri-
bution options were studied. Finally for the donation the 
participant will receive a USB with preventive information 
on cannabis. Minimal changes were done to adapt the ques-
tionnaire. One example is the question on the type of de-
rivate consumed, which was adapted to retrieve more than 
one option of consumption. This change was especially ne-
cessary for home-grown marihuana users, which occasiona-
lly also acquire cannabis. For the final study, these users will 
be asked to estimate the value (price) of their own cultivated 
cannabis. 
Preliminary data on the Standard Joint Unit
To optimize our study resources, for the SJU only joints 
of the most prevalent types (marihuana and hashish) will be 
considered. Few donations of other joints are expected and 
might be discouraged due to higher prices. 
The numbers of joints rolled with one gram of cannabis 
were comparable within marihuana and hashish (approxi-
mately 4 joints with 1gr of cannabis). This data is consistent 
with previous studies (van der Pol et al., 2013; van der Pol et 
al., 2014). Other comparable studies like the published by 
Norberg et al (2012) stated that a Standard Cannabis Unit ac-
counted for 0.25gr of cannabis (Norberg et al., 2012), which 
is similar to our results. In our larger study, these data will be 
analyzed considering amounts of tobacco (%) and concen-
trations of the main cannabinoids (9-THC and CBD). The 
analytical procedure to quantify the cannabinoids was valida-
ted and will proceed following the recommendations of the 
UNODC (United Nations Office on Drug and Crime, 2009). 
Most of our sample declared to roll their joints similarly 
every time (85%) and not sharing it (68.5%). Considering 
that most of our participants are nearly daily smokers of 2 
to 4 joints per day, consuming up to 1gr of cannabis daily or 
nearly daily may not be uncommon among these cannabis 
users of Barcelona. 
Information retrieved is believed to be consistent due to 
the high proportion of frequent users, who mostly roll their 
joints similarly every time and do not share them. These 
data include prices, grams acquired per occasion and num-
ber joints resulting from a specific cannabis amount. In con-
sequence, proceeding to analyze the joints donated by the 
participants in the real study was decided.
Associations between quantity consumed and CAST results 
will be analyzed in the larger study. Preliminary data obtained 
through the pre-test indicate a significant prevalence of users 
having a high risk of suffering cannabis related problems. Ac-
cording to the definition of the European Monitoring Centre 
for Drugs and Drug Addiction, users consuming at least 20 
days in the last month are high-risk users (EMCDDA, 2004). 
In our sample 70% declared to use cannabis on more than 20 
days in the last month. With the CAST, 58% were categorized 
as high-risk users (CAST>4). The last edition of the Spanish 
National Survey on Drugs found that beyond cannabis users 
in the last year, prevalence of problematic cannabis use was 
25% (Delegación del Gobierno para Plan Nacional sobre 
Drogas, 2015). Associations with reasons for consumption 
will be explored and may reveal important data on personal 
risks as suggested in previous studies (Aleixandre, Río, & Pol, 
2004; González, Sáiz, Quirós, & López, 2000).
Strengths and limitations
Reporting all phases of the study will contribute to the 
understanding of the SJU. Working on a SJU which consi-
ders quantity of 9-THC is innovative and to our knowledge 
no other feasibility reports have been published. With the 
pilot test we have been able to explore crucial aspects of 
the study, as for example the donation of joints. The pilot 
test has helped to improve our methodology and to avoid 
unnecessary costs. 
The hetero-administered questionnaire may potentially 
have induced an information bias. Bivariate statistical analy-
ses were not performed as variable categories were in some 
cases too infrequent. Nevertheless, pilot studies are meant 
to explore feasibility and adequacy of the study procedure.
Conclusions
The pilot test contributed to optimize our methodology, 
enhancing the likelihood of establishing a SJU. Standardized 
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cannabis assessment which considers quantity is essential to 
explore which patterns of cannabis use increase the risk of 
suffering negative consequences. Due to cannabis high preva-
lence of use and its implications for public health, improving 
evidence-based knowledge on cannabis risks is highly needed.
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